Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-000276-10Phase 2Completed
Phase 2, randomised, double-blind trial in fish allergy and food allergy comparing mCyp c 1 SCIT with Placebo (2 arms). Primary endpoints: Change in fish protein reaction threshold and DBPCFC success criterion. Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-000276-10.